59 research outputs found
Rational Asymmetric Development: Transfer Pricing and Sub-Saharan Africa's Extreme Poverty Tragedy
Chronic kidney disease after liver, cardiac, lung, heart–lung, and hematopoietic stem cell transplant
Patient survival after cardiac, liver, and hematopoietic stem cell transplant (HSCT) is improving; however, this survival is limited by substantial pretransplant and treatment-related toxicities. A major cause of morbidity and mortality after transplant is chronic kidney disease (CKD). Although the majority of CKD after transplant is attributed to the use of calcineurin inhibitors, various other conditions such as thrombotic microangiopathy, nephrotic syndrome, and focal segmental glomerulosclerosis have been described. Though the immunosuppression used for each of the transplant types, cardiac, liver and HSCT is similar, the risk factors for developing CKD and the CKD severity described in patients after transplant vary. As the indications for transplant and the long-term survival improves for these children, so will the burden of CKD. Nephrologists should be involved early in the pretransplant workup of these patients. Transplant physicians and nephrologists will need to work together to identify those patients at risk of developing CKD early to prevent its development and progression to end-stage renal disease
HIV and Hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis
A1 adenosine receptor attenuates intracerebral hemorrhage-induced secondary brain injury in rats by activating the P38-MAPKAP2-Hsp27 pathway
Circulating Antibodies to Cardiac Protein—Acetaldehyde Adducts in Alcoholic Heart Muscle Disease
Enterovirus RNA Replication in Cases of Dilated Cardiomyopathy: Light Microscopic In Situ Hybridization and Virological Analyses of Myocardial Specimens Obtained at Partial Left Ventriculectomy
- …